Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
BMJ Open. 2013 Aug 30;3(8):e003423. doi: 10.1136/bmjopen-2013-003423.
OBJECTIVE: Comparison of recent national survey data on prevalence, awareness, treatment and control of hypertension in England, the USA and Canada, and correlation of these parameters with each country stroke and ischaemic heart disease (IHD) mortality. DESIGN: Non-institutionalised population surveys. SETTING AND PARTICIPANTS: England (2006 n=6873), the USA (2007-2010 n=10 003) and Canada (2007-2009 n=3485) aged 20-79 years. OUTCOMES: Stroke and IHD mortality rates were plotted against countries' specific prevalence data. RESULTS: Mean systolic blood pressure (SBP) was higher in England than in the USA and Canada in all age-gender groups. Mean diastolic blood pressure (DBP) was similar in the three countries before age 50 and then fell more rapidly in the USA, being the lowest in the USA. Only 34% had a BP under 140/90 mm Hg in England, compared with 50% in the USA and 66% in Canada. Prehypertension and stages 1 and 2 hypertension prevalence figures were the highest in England. Hypertension prevalence (≥140 mm Hg SBP and/or ≥90 mm Hg DBP) was lower in Canada (19·5%) than in the USA (29%) and England (30%). Hypertension awareness was higher in the USA (81%) and Canada (83%) than in England (65%). England also had lower levels of hypertension treatment (51%; USA 74%; Canada 80%) and control (<140/90 mm Hg; 27%; the USA 53%; Canada 66%). Canada had the lowest stroke and IHD mortality rates, England the highest and the rates were inversely related to the mean SBP in each country and strongly related to the blood pressure indicators, the strongest relationship being between low hypertension awareness and stroke mortality. CONCLUSIONS: While the current prevention efforts in England should result in future-improved figures, especially at younger ages, these data still show important gaps in the management of hypertension in these countries, with consequences on stroke and IHD mortality.
目的:比较英格兰、美国和加拿大最近的全国高血压患病率、知晓率、治疗率和控制率调查数据,并分析这些参数与各国脑卒中及缺血性心脏病(IHD)死亡率的相关性。 方法:非机构人群调查。 地点和参与者:英格兰(2006 年 n=6873)、美国(2007-2010 年 n=10003)和加拿大(2007-2009 年 n=3485)年龄在 20-79 岁之间的非住院人群。 结果:将各国具体的患病率数据与脑卒中及 IHD 死亡率进行了绘图比较。 结果:在所有年龄-性别组中,英格兰的平均收缩压(SBP)均高于美国和加拿大。在三个国家中,50 岁前的平均舒张压(DBP)相似,随后美国的 DBP 下降速度更快,DBP 最低。在英格兰,仅有 34%的人血压低于 140/90mmHg,而美国为 50%,加拿大为 66%。在英格兰,高血压前期和 1 期和 2 期高血压的患病率最高。加拿大(19.5%)的高血压患病率(SBP≥140mmHg 和/或 DBP≥90mmHg)低于美国(29%)和英格兰(30%)。美国(81%)和加拿大(83%)的高血压知晓率高于英格兰(65%)。英格兰的高血压治疗率(51%;美国为 74%;加拿大为 80%)和控制率(<140/90mmHg;27%;美国为 53%;加拿大为 66%)较低。加拿大的脑卒中及 IHD 死亡率最低,英格兰最高,且这些比率与各国的平均 SBP 呈反比,与血压指标密切相关,与高血压知晓率的关系最强。 结论:虽然英格兰目前的预防措施应会导致未来数据的改善,尤其是在年轻人群中,但这些数据仍表明这些国家在高血压管理方面存在重要差距,这对脑卒中及 IHD 死亡率有影响。
Am J Hypertens. 2001-11
Dan Med J. 2014-7
Circulation. 2018-2-15
Zhonghua Xin Xue Guan Bing Za Zhi. 2022-12-24
Indian J Community Med. 2025
Healthcare (Basel). 2025-6-11
Patient Prefer Adherence. 2025-5-13
Chronic Dis Transl Med. 2023-6-14
Am J Epidemiol. 2011-3-9
Health Rep. 2010-3
J Hypertens. 2009-7